Age (per year)
|
295
|
1.05 (1.03,1.07)
|
1.05 (1.03,1.08) ₤
|
1.04 (1.02,1.07) ₤
|
Gender (Females vs. males)
|
295
|
0.46 (0.23,0.92)
|
0.43 (0.21,0.87) €
|
0.37 (0.18,0.78) €
|
BMI (per kg/m2)
|
290
|
0.91 (0.85,0.97)
|
0.93 (0.87,1.00)
|
0.96 (0.86,1.07)
|
Waist circumference (per inch)
|
294
|
0.96(0.91,1.02)
|
0.94(0.88,1.00)
|
0.94 (0.88,1.00)
|
Waist-hip ratio (per unit)
|
294
|
1.11(0.77,1.60)
|
0.72(0.45,1.16)
|
0.92 (0.49,1.74)
|
Cigarette use (Ever vs. never)
|
295
|
1.01 (1.00,1.03)
|
1.01 (0.99,1.03)
|
0.99 (0.96,1.03)
|
Pack-years continuous (per pack-year)
|
295
|
1.01 (1.00,1.02)
|
1.01 (1.00,1.02)
|
1.01 (1.00,1.02)
|
Pack-years Tertiles
| | | |
-
|
Non-smokers
| |
REF
|
REF
|
REF
|
T1 (0.05-)
| |
0.58 (0.28,1.20)
|
0.64 (0.30,1.35)
|
0.64 (0.30,1.37)
|
T2 (14-)
| |
0.91 (0.47,1.76)
|
0.79 (0.40,1.57)
|
0.84 (0.42,1.70)
|
T3 (36-)
| |
1.58 (0.83,3.01)
|
1.30 (0.66,2.56)
|
1.40 (0.70,2.77)
|
p-trendb
| |
0.04**
|
0.27
|
0.20
|
Leptin (ng/ml)
|
226
|
0.98 (0.95,1.01)
|
1.00 (0.97,1.04)
|
1.05 (1.01,1.12)
|
Total Adiponectin (mcg/ml)
|
226
|
1.08 (0.97,1.20)
|
1.00 (0.88,1.15)
|
0.98 (0.85,1.12)
|
HMW Adiponectin (mcg/ml)
|
226
|
1.10 (0.92,1.30)
|
0.98 (0.79,1.21)
|
0.92 (0.74,1.15)
|
Glucose (mg/dL)
|
226
|
0.99 (0.98,1.01)
|
0.99 (0.97,1.01)
|
0.99 (0.97,1.01)
|
Insulin (uU/ml)
|
226
|
1.00 (0.95,1.04)
|
1.00 (0.95,1.05)
|
1.02 (0.97,1.07)
|
HOMA score
|
226
|
0.95 (0.82,1.09)
|
0.95 (0.81,1.12)
|
1.01 (0.86,1.18)
|
CRP continuous (mg/L)
|
222
|
0.98 (0.87,1.11)
|
0.95 (0.82,1.09)
|
0.98 (0.84,1.13)
|
CRP Tertiles
| | | | |
T1 (0.1-)
| |
REF
|
REF
|
REF
|
T2 (1.1-)
| |
1.36 (0.67,2.74)
|
1.40 (0.66,2.96)
|
1.69 (0.78,3.68)
|
T3 (2.9-)
| |
0.91 (0.45,1.85)
|
0.81 (0.37,1.78)
|
1.04 (0.45,2.40)
|
p-trendb
| |
0.74
|
0.44
|
0.74
|
IL-6 continuous (pg/ml)
|
234
|
1.06 (0.95,1.17)
|
1.02 (0.90,1.15)
|
1.04 (0.92,1.18)
|
IL-6 Tertiles
| | | | |
T1 (0.4-)
| |
REF
|
REF
|
REF
|
T2 (1.5-)
| |
1.45 (0.74,2.86)
|
1.21 (0.58,2.50)
|
1.25 (0.59,2.62)
|
T3 (2.6-)
| |
1.25 (0.63-2.47)
|
1.07 (0.50,2.31)
|
1.22 (0.55,2.71)
|
p-trendb
| |
0.32
|
0.77
|
0.51
|
sTNF-RI continuous (ng/ml)
|
234
|
3.30 (1.75,6.23)
|
2.02 (1.02,3.99)
|
2.30 (1.11,4.78)
|
sTNF-RI Tertiles
| | | | |
T1 (0.3-)
| |
REF
|
REF
|
REF
|
T2 (1.2-)
| |
1.14 (0.56,2.33)
|
0.90 (0.42,1.91)
|
1.00 (0.46,2.15)
|
T3 (1.5-)
| |
3.25 (1.64,6.43)
|
1.81 (0.85,3.84)
|
2.19 (1.00,4.85)
|
p-trendb
| |
<0.001**
|
0.04**
|
0.02 **
|
sTNF-RII continuous (ng/ml)
|
234
|
1.30 (1.07,1.58)
|
1.08 (0.86,1.35)
|
1.06 (0.84,1.33)
|
sTNF-RII Tertiles
| | | | |
T1 (2.1-)
| |
REF
|
REF
|
REF
|
T2 (4.9-)
| |
0.90 (0.44,1.82)
|
0.64 (0.30,1.37)
|
0.68 (0.32,1.47)
|
T3 (6.0-)
| |
2.52 (1.29,4.90)
|
1.42 (0.66,3.04)
|
1.45 (0.67,3.15)
|
p-trendb
| |
0.01**
|
0.50
|
0.62
|
F2-isoprostanes continuous (pg/ml)
|
224
|
1.00 (0.99,1.01)
|
1.00 (1.00,1.01)
|
1.01 (1.00,1.02)
|
F2-isoprostane Tertiles
| | | | |
T1 (14-)
| |
REF
|
REF
|
REF
|
T2 (48-)
| |
0.62 (0.31,1.25)
|
0.67 (0.32,1.41)
|
0.72 (0.34,1.52)
|
T3 (67-)
| |
0.93 (0.48,1.83)
|
1.28 (0.60,2.71)
|
1.55 (0.71,3.39)
|
p-trendb
| |
0.88
|
0.31
|
0.18
|